Every 10-Q that ClearOne, Inc. (CLRO) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow CLRO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CLRO filings page.
ClearOne, Inc. reported results for the quarter ended June 30, 2026 in a wind‑down, pre‑merger state. After selling substantially all operating assets in October 2025, the company has no revenue‑generating operations; activities are limited to warranty support, compliance, and pursuing a merger with Cortigent, Inc.
Total assets were $990 thousand, including cash and cash equivalents of $75 thousand and restricted cash of $447 thousand, against total liabilities of $1.371 million, resulting in negative shareholders’ equity of $381 thousand. For the six months, loss from continuing operations was $1.769 million, and total net loss was $1.401 million, improved from a $7.406 million loss a year earlier when the product business was still active.
The company obtained a related‑party loan facility from its largest shareholder, First Finance, for up to $1.0 million at 11% interest; $500 thousand was outstanding at June 30, 2026 and most undrawn proceeds were restricted. Management states that recurring losses, minimal cash, and the lack of revenue create substantial doubt about the ability to continue as a going concern. Plans to address this depend on closing a reverse‑recapitalization merger with Cortigent and a concurrent S‑1 unit offering of $10–$15 million, both subject to market, regulatory, stockholder, and Nasdaq initial‑listing conditions.
ClearOne’s Q1 2026 report shows a shell-like company focused on wind-down and strategic options rather than operations. Following the October 2025 $3.0 million asset sale to Biamp, continuing operations generated no revenue and posted a $850 thousand loss from continuing operations.
Including a $363 thousand profit from discontinued operations and a $793 thousand tax benefit release, net loss narrowed to $487 thousand versus $2.834 million a year earlier. Cash and cash equivalents were $1.053 million as of March 31, 2026, supported by a $1.750 million March 2026 private placement with major holder First Finance Ltd.
Management highlights “substantial doubt” about the company’s ability to continue as a going concern, given ongoing losses, minimal revenue, and limited operations. Subsequent events include a Nasdaq deficiency notice over continued listing standards, termination of the main office lease, redemption of Class A preferred shares, and completion of reincorporation from Delaware to Nevada.
ClearOne, Inc. reported continuing operational stress and liquidity uncertainty for the six months ended June 30, 2025. The company used $2.6 million of cash in operating activities year-to-date and cites substantial doubt about its ability to continue as a going concern unless it completes strategic transactions, generates inventory sales, or raises additional capital. Management pursued an Asset Sale process, issued a $3.0 million convertible note with $1,678 of restricted proceeds remaining, and effected a 1-for-15 reverse stock split to regain Nasdaq compliance; the company regained compliance on June 24, 2025. A workforce reduction was implemented on June 20, 2025, with estimated severance costs of approximately $1.9 million. Revenue and inventory were negatively impacted by past production shortages, including a reported 73% decline in Asia Pacific revenues compared to prior year quarter.